NUVISAN The Science CRO
Anders Friberg is a Senior Scientist and Lab Head at Nuvisan Pharma Services since July 2020. Prior to that, Anders worked at Bayer Pharmaceuticals as a Research Scientist and Lab Head from January 2014 to June 2020. Anders has a background in drug discovery, cancer biology, computational chemistry, and research on protein structures and interactions. Anders completed their Ph.D. and postdoctoral fellowships at Technical University of Munich, EMBL Heidelberg, and Vanderbilt University. Anders holds a M.Sc. in Biotechnology and Biomolecular Chemistry from KTH Royal Institute of Technology.
This person is not in the org chart
NUVISAN The Science CRO
1 followers
Founded in Europe with more than 40 years of experience, NUVISAN is a fully integrated contract research and development, and manufacturing organization (CRO/CDMO) that offers unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain. With more than 1.000 employees distributed over six locations in Germany and France including our drug discovery hub in Berlin as well as with local experts situated in Latin America, NUVISAN is pleased to offer the following portfolio of services: • Drug discovery & research - Discovery pharmacology - Discovery bioscience - Screening - Life science chemistry - Translation research - Digital life science - Toxicology - DMPK • Non-clinical studies • Pharmaceutical analysis • Topical formulation development • Chemical development with GMP manufacturing (3-10kg) • Bioanalytical labs • GMP manufacturing (up to 50Kg) • Clinical trial supplies • Phase 1 and 2 clinical studies and beyond Our services can be provided as stand-alone or integrated solutions and can be customized to your project. Email us at hello@nuvisan.com for more.